nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—GPC5—multiple sclerosis	0.106	0.237	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—GPC5—multiple sclerosis	0.0543	0.121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOE—multiple sclerosis	0.0305	0.0678	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.026	0.0578	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ALB—multiple sclerosis	0.0204	0.0453	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—multiple sclerosis	0.0156	0.0346	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0142	0.0316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0142	0.0316	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Fingolimod—multiple sclerosis	0.0141	0.0257	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Cladribine—multiple sclerosis	0.0138	0.025	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.0124	0.0226	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Fingolimod—multiple sclerosis	0.0124	0.0226	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Azathioprine—multiple sclerosis	0.0112	0.0203	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Fingolimod—multiple sclerosis	0.0103	0.0188	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Cladribine—multiple sclerosis	0.01	0.0182	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.00998	0.0181	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Cladribine—multiple sclerosis	0.00987	0.0179	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Fingolimod—multiple sclerosis	0.00986	0.0179	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Fingolimod—multiple sclerosis	0.00953	0.0173	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Fingolimod—multiple sclerosis	0.00903	0.0164	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SRM—multiple sclerosis	0.00897	0.02	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Cladribine—multiple sclerosis	0.00801	0.0146	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Cladribine—multiple sclerosis	0.0071	0.0129	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00705	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Cladribine—multiple sclerosis	0.00704	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—GPC5—multiple sclerosis	0.0069	0.0154	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00668	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LINGO1—multiple sclerosis	0.00655	0.0146	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Cladribine—multiple sclerosis	0.00646	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP27B1—multiple sclerosis	0.00632	0.0141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP24A1—multiple sclerosis	0.00632	0.0141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00618	0.0137	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Cladribine—multiple sclerosis	0.00586	0.0106	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPC5—multiple sclerosis	0.00578	0.0129	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00574	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TAGAP—multiple sclerosis	0.00568	0.0126	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Cladribine—multiple sclerosis	0.00559	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00543	0.00987	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Cladribine—multiple sclerosis	0.0054	0.00982	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Azathioprine—multiple sclerosis	0.00525	0.00954	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cladribine—multiple sclerosis	0.0052	0.00944	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Cladribine—multiple sclerosis	0.00515	0.00936	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Cladribine—multiple sclerosis	0.00515	0.00935	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Cladribine—multiple sclerosis	0.00512	0.0093	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—S1PR1—multiple sclerosis	0.00497	0.0111	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Methylprednisolone—multiple sclerosis	0.00495	0.009	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cladribine—multiple sclerosis	0.00485	0.00882	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GPC5—multiple sclerosis	0.00483	0.0108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RRM1—multiple sclerosis	0.00479	0.0107	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00473	0.00859	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00467	0.00848	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mitoxantrone—multiple sclerosis	0.00463	0.00841	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Azathioprine—multiple sclerosis	0.00455	0.00826	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00451	0.00819	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—RPL5—multiple sclerosis	0.00449	0.00998	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Azathioprine—multiple sclerosis	0.00439	0.00798	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00439	0.00798	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC11A1—multiple sclerosis	0.0043	0.00956	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00425	0.00771	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Azathioprine—multiple sclerosis	0.00422	0.00767	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RGS1—multiple sclerosis	0.00422	0.0094	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Azathioprine—multiple sclerosis	0.00419	0.00761	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Azathioprine—multiple sclerosis	0.00419	0.0076	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Azathioprine—multiple sclerosis	0.00416	0.00756	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GPR65—multiple sclerosis	0.004	0.00891	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00396	0.0072	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Azathioprine—multiple sclerosis	0.00395	0.00717	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Prednisone—multiple sclerosis	0.00392	0.00713	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mitoxantrone—multiple sclerosis	0.00385	0.007	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00372	0.00827	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00367	0.00668	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR1—multiple sclerosis	0.00366	0.00815	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL13—multiple sclerosis	0.00366	0.00815	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00361	0.00655	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00361	0.00655	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Triamcinolone—multiple sclerosis	0.00357	0.00648	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00356	0.00646	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Triamcinolone—multiple sclerosis	0.00349	0.00635	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methylprednisolone—multiple sclerosis	0.00349	0.00633	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD28—multiple sclerosis	0.00343	0.00763	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Mitoxantrone—multiple sclerosis	0.00341	0.0062	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mitoxantrone—multiple sclerosis	0.00339	0.00615	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00338	0.00615	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mitoxantrone—multiple sclerosis	0.00336	0.00611	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00331	0.00601	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Methotrexate—multiple sclerosis	0.00328	0.00596	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Betamethasone—multiple sclerosis	0.00324	0.00588	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Dexamethasone—multiple sclerosis	0.00324	0.00588	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.0032	0.00581	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Dexamethasone—multiple sclerosis	0.0032	0.00581	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Betamethasone—multiple sclerosis	0.0032	0.00581	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00319	0.0071	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Mitoxantrone—multiple sclerosis	0.00319	0.00579	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00317	0.00577	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00317	0.00577	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dexamethasone—multiple sclerosis	0.00317	0.00576	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Betamethasone—multiple sclerosis	0.00317	0.00576	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Prednisone—multiple sclerosis	0.00314	0.0057	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00301	0.00546	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00301	0.00546	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Prednisolone—multiple sclerosis	0.00291	0.00529	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.00291	0.00647	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Triamcinolone—multiple sclerosis	0.00291	0.00528	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Betamethasone—multiple sclerosis	0.00291	0.00528	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dexamethasone—multiple sclerosis	0.00291	0.00528	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Methylprednisolone—multiple sclerosis	0.0029	0.00527	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Prednisone—multiple sclerosis	0.00282	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Prednisone—multiple sclerosis	0.00278	0.00506	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Prednisolone—multiple sclerosis	0.00278	0.00505	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisolone—multiple sclerosis	0.00278	0.00504	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00277	0.00502	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Prednisone—multiple sclerosis	0.00276	0.00501	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Prednisolone—multiple sclerosis	0.00276	0.00501	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BCHE—multiple sclerosis	0.00275	0.00612	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Triamcinolone—multiple sclerosis	0.00268	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Methylprednisolone—multiple sclerosis	0.00267	0.00486	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Betamethasone—multiple sclerosis	0.00264	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Dexamethasone—multiple sclerosis	0.00264	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Methotrexate—multiple sclerosis	0.00262	0.00477	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00262	0.00476	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Prednisolone—multiple sclerosis	0.00262	0.00475	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL3—multiple sclerosis	0.00261	0.00581	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Triamcinolone—multiple sclerosis	0.00258	0.00468	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Methylprednisolone—multiple sclerosis	0.00257	0.00467	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Triamcinolone—multiple sclerosis	0.00255	0.00464	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Triamcinolone—multiple sclerosis	0.00255	0.00464	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Methylprednisolone—multiple sclerosis	0.00255	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methylprednisolone—multiple sclerosis	0.00255	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Triamcinolone—multiple sclerosis	0.00254	0.00461	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methylprednisolone—multiple sclerosis	0.00253	0.0046	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Prednisone—multiple sclerosis	0.00253	0.0046	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Dexamethasone—multiple sclerosis	0.00252	0.00457	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Betamethasone—multiple sclerosis	0.00252	0.00457	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTGER4—multiple sclerosis	0.00251	0.00559	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGR—multiple sclerosis	0.00247	0.0055	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD86—multiple sclerosis	0.00245	0.00545	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Betamethasone—multiple sclerosis	0.00243	0.00442	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Dexamethasone—multiple sclerosis	0.00243	0.00442	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR3—multiple sclerosis	0.00243	0.0054	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Triamcinolone—multiple sclerosis	0.00241	0.00437	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD28—multiple sclerosis	0.0024	0.00535	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Methylprednisolone—multiple sclerosis	0.0024	0.00436	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR2—multiple sclerosis	0.00236	0.00525	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Methotrexate—multiple sclerosis	0.00236	0.00428	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Betamethasone—multiple sclerosis	0.00234	0.00425	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dexamethasone—multiple sclerosis	0.00234	0.00425	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Methotrexate—multiple sclerosis	0.00233	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Dexamethasone—multiple sclerosis	0.00232	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Betamethasone—multiple sclerosis	0.00232	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Dexamethasone—multiple sclerosis	0.00232	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Betamethasone—multiple sclerosis	0.00232	0.00421	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00231	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methotrexate—multiple sclerosis	0.00231	0.00419	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Betamethasone—multiple sclerosis	0.0023	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Dexamethasone—multiple sclerosis	0.0023	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Prednisone—multiple sclerosis	0.0023	0.00417	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Prednisone—multiple sclerosis	0.00219	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00219	0.00397	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dexamethasone—multiple sclerosis	0.00218	0.00397	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Betamethasone—multiple sclerosis	0.00218	0.00397	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR1—multiple sclerosis	0.00218	0.00485	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CCR5—multiple sclerosis	0.00217	0.00483	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Prednisone—multiple sclerosis	0.00212	0.00385	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HLA-A—multiple sclerosis	0.00212	0.00471	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Methotrexate—multiple sclerosis	0.00212	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Prednisone—multiple sclerosis	0.00204	0.0037	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Prednisone—multiple sclerosis	0.00202	0.00367	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Prednisone—multiple sclerosis	0.00202	0.00366	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Prednisone—multiple sclerosis	0.00201	0.00364	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—multiple sclerosis	0.00198	0.0044	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL10—multiple sclerosis	0.00196	0.00436	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Methotrexate—multiple sclerosis	0.00192	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Prednisone—multiple sclerosis	0.0019	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methotrexate—multiple sclerosis	0.00183	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD80—multiple sclerosis	0.00179	0.00397	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Methotrexate—multiple sclerosis	0.00177	0.00321	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD86—multiple sclerosis	0.00171	0.00381	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Methotrexate—multiple sclerosis	0.0017	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL5—multiple sclerosis	0.00169	0.00376	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Methotrexate—multiple sclerosis	0.00169	0.00306	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methotrexate—multiple sclerosis	0.00169	0.00306	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methotrexate—multiple sclerosis	0.00168	0.00305	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—multiple sclerosis	0.00165	0.00368	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Methotrexate—multiple sclerosis	0.00159	0.00289	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPP1—multiple sclerosis	0.00156	0.00348	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR5—multiple sclerosis	0.00152	0.00338	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TYK2—multiple sclerosis	0.00151	0.00335	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2RA—multiple sclerosis	0.0015	0.00333	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—multiple sclerosis	0.00142	0.00316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—multiple sclerosis	0.00138	0.00308	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD4—multiple sclerosis	0.00136	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—multiple sclerosis	0.0013	0.00288	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD80—multiple sclerosis	0.00125	0.00278	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—multiple sclerosis	0.00119	0.00264	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—multiple sclerosis	0.00116	0.00259	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TYK2—multiple sclerosis	0.00106	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—multiple sclerosis	0.00106	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—multiple sclerosis	0.000981	0.00218	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—multiple sclerosis	0.000979	0.00218	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK1—multiple sclerosis	0.00096	0.00214	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—multiple sclerosis	0.000879	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—multiple sclerosis	0.000832	0.00185	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—multiple sclerosis	0.000739	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—multiple sclerosis	0.000738	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—multiple sclerosis	0.000687	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—multiple sclerosis	0.000685	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK1—multiple sclerosis	0.000672	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—multiple sclerosis	0.000516	0.00115	CbGpPWpGaD
